Gong, Jun
Thomassian, Shant
Kim, Sungjin
Gresham, Gillian
Moshayedi, Natalie
Ye, Jason Y.
Yang, Julianne C.
Jacobs, Jonathan P.
Lo, Simon
Nissen, Nick
Gaddam, Srinivas
Tighiouart, Mourad
Osipov, Arsen
Hendifar, Andrew
Clinical trials referenced in this document:
Documents that mention this clinical trial
Phase I trial of Bermekimab with nanoliposomal irinotecan and 5-fluorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma
https://doi.org/10.1038/s41598-022-19401-3
Article History
Received: 26 April 2022
Accepted: 29 August 2022
First Online: 2 September 2022
Change Date: 4 November 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41598-022-23619-6
Competing interests
: The authors declare no competing interests.